Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China flag China · Delayed Price · Currency is CNY
89.55
+2.04 (2.33%)
Dec 25, 2025, 9:25 AM CST
207.10%
Market Cap14.26B
Revenue (ttm)430.98M
Net Income (ttm)-197.25M
Shares Out159.27M
EPS (ttm)-1.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume46,400
Average Volume4,719,864
Open86.00
Previous Close87.51
Day's Range86.00 - 90.00
52-Week Range24.44 - 188.93
Beta1.17
RSI42.81
Earnings DateApr 17, 2026

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 760
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300436
Full Company Profile

Financial Performance

In 2024, SHE:300436's revenue was 441.46 million, an increase of 4.43% compared to the previous year's 422.71 million. Losses were -156.30 million, -55.16% less than in 2023.

Financial Statements

News

There is no news available yet.